SCHEMBL4383637

SCHEMBL4383637

CSc1nc2cnc3cccnc3c2n1Cc1ccccc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
POLB P06746 2/20 0.45
BRAF P15056 1/20 0.44
HTT P42858 2/20 0.44
TSHR P16473 1/20 0.44
ALDH1A1 P00352 2/20 0.43
MAPT P10636 2/20 0.41
KMT2A Q03164 2/20 0.40
L3MBTL1 Q9Y468 1/20 0.40
ATM Q13315 2/20 0.40
HPGD P15428 1/20 0.40
PDE4A P27815 1/20 0.40
PDE4B Q07343 1/20 0.40
PDE4C Q08493 1/20 0.40
PDE4D Q08499 1/20 0.40
KDM4E B2RXH2 2/20 0.39
CYP1A2 P05177 2/20 0.39
CYP2C19 P33261 2/20 0.39
BRD4 O60885 1/20 0.39
CYP2C9 P11712 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL212874 0.84 POLB (0.48) POLBBRAFHTTTSHRALDH1A1
SCHEMBL4377042 0.80 PDE4A (0.41) HTTALDH1A1KMT2AATMPDE4A
SCHEMBL4381598 0.79 CYP2C19 (0.58) POLBTSHRALDH1A1KMT2AL3MBTL1
SCHEMBL3353822 0.77 AVPR1A (0.43) TSHRMAPTKMT2APDE4APDE4B
SCHEMBL202268 0.71 KDM4E (0.41) HTTL3MBTL1KDM4ECYP2C19BRD4
SCHEMBL3355129 0.70 TLR7 (0.44) HTTMAPTKMT2ACYP1A2CYP2C19
SCHEMBL5025892 0.70 LMNA (0.66) POLBALDH1A1KMT2AL3MBTL1PDE4A
SCHEMBL191697 0.69 LMNA (0.39) POLBHTTTSHRALDH1A1MAPT
SCHEMBL19771402 0.69 TP53 (0.56) POLBMAPT
SCHEMBL4380182 0.69 KDM4E (0.49) POLBALDH1A1KMT2AKDM4ECYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8329721-B2 Hydroxy and alkoxy substituted 1H-imidazonaphthyridines and methods 3M INNOVATIVE PROPERTIES COMPANY (US) 2012-12-11 US disclosed
US-20090298821-A1 HYDROXY AND ALKOXY SUBSTITUTED IH-IMIDAZONAPHTHYRIDINES AND METHODS PFIZER INC. 2009-12-03 US disclosed
WO-2007106854-A2 HYDROXY AND ALKOXY SUBSTITUTED 1H-IMIDAZONAPHTHYRIDINES AND METHODS COLEY PHARMACEUTICAL GROUP, INC. (US) 2007-09-20 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090298821-A1 HYDROXY AND ALKOXY SUBSTITUTED IH-IMIDAZONAPHTHYRIDINES AND METHODS IL2, IL4, IFNG POLB 1823/4885BRAF 2590/4885HTT 259/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.